-
UCL start-up Novai raises £500,000 for AI tech
pharmatimes
July 24, 2020
Novai, a biotechnology startup out of University College London, has secured £500,000 in seed funding in a round led by SFC Capital.
-
Study is first to identify potential therapeutic targets for COVID-19
worldpharmanews
June 29, 2020
A team from Lawson Health Research Institute and Western University are the first in the world to profile the body's immune response to COVID-19.
-
Artificial Intelligence (AI) Sector is Leveraging Their Technology to Detect Outbreaks, Enable Effective Contact Tracing and Identify Existing Drugs to Treat COVID-19
prnewswire
June 19, 2020
Artificial intelligence is being used in new ways in response to the COVID-19 pandemic. Several companies like BlueDot, IBM and BenevolentAI are leveraging their technologies to detect outbreaks.
-
Researchers develop AI tool able to predict cancer relapse
pharmatimes
May 29, 2020
A team of computer scientists and pathologists have trained an artificial intelligence (AI) tool to identify lung cancer patients who have a higher risk of disease recurrence following treatment.
-
Atomwise leverages AI to explore broad-spectrum Covid-19 drugs
pharmaceutical-technology
May 26, 2020
Atomwise has forged fifteen research collaborations with universities globally to develop broad-spectrum treatments for Covid-19, as well as other coronaviruses.
-
Ultromics, Mayo Clinic Collaborate to Rapidly Assess COVID-19 Patients Using AI
americanpharmaceuticalreview
May 13, 2020
A joint UK-US research team is applying an artificial intelligence system to map for the first time how the COVID-19 virus attacks the heart with such deadly impact.
-
Aberdeen Uni proceeds with COVID-19 mass screening research
pharmatimes
May 07, 2020
Researchers at the University of Aberdeen plan to use artificial intelligence (AI) to try to fast-track a test to allow mass screening for COVID-19, after the £140,000 project was approved by the Scottish government.
-
Technology has driven success in pharma industry in many perceptible ways
expresspharma
April 30, 2020
Gyan Pandey, Global and Group CIO, Aurobindo Pharma, explains that digitalisation is not a one-time process, but an evolving journey.
-
AI can play a big role in vaccine development for COVID-19
expresspharma
April 30, 2020
Many believe that AI has the potential to complement the scientific community in major breakthroughs, especially in developing vaccines for COVID-19.
-
Real-world evidence the most impactful emerging technology in COVID-19 management: Poll
pharmaceutical-technology
April 23, 2020
New-age emerging technologies are projected to have a significant impact on managing the coronavirus pandemic (COVID-19).